Literature DB >> 8436905

Changes in the repertoire of peptides bound to HLA-B27 subtypes and to site-specific mutants inside and outside pocket B.

S Rojo1, F García, J A Villadangos, J A López de Castro.   

Abstract

HLA-B27 subtypes share many structural features, including their pocket B, which interacts with a conserved Arg residue at the second position of B*2705-bound peptides. Subtypes differ among each other at other locations in the peptide binding site. In this study, metabolic labeling and radiochemical pool sequencing were used to address the following issues: (a) presence of the Arg 2 (R2) motif among peptides bound to the various HLA-B27 subtypes; (b) influence of mutations inside and outside pocket B on this motif; and (c) the degree of similarity among the peptide pools bound to the various B27 subtypes. Sequencing of Arg-labeled peptide pools extracted from B*2701 to B*2706, and from two site-directed mutants of B*2705 with changes outside pocket B, indicated that all of these molecules bind peptides with Arg at position 2. Peptides from several mutants with changes altering the structure of pocket B, and from one mutant at the pocket B rim, also retained the R2 motif. However, this was absent in the peptide pool extracted from the M45 mutant, in which the negative charge of pocket B, conferred to HLA-B27 by Glu45, was canceled. These results indicate that alterations outside pocket B, and even disruption of the network of hydrogen bonds that stabilizes Arg binding in pocket B, do not impair binding of peptides bearing the R2 motif, but a nonconservative substitution at position 45 does. As a substantial fraction of anti-B*2705 cytotoxic T lymphocyte (CTL) clones crossreact with the M45 mutant (Villadangos, J., B. Galocha, D. López, V. Calvo, and J. A. López de Castro. 1992. J. Immunol. 149:505) this result suggest that determinant mimicry by nonidentical peptides may frequently account for unexpected CTL crossreactions. Metabolic labeling with various other amino acids and radiochemical sequencing revealed similarities, but also substantial differences, among the peptide pools from the various HLA-B27 subtypes. This strongly suggests that many peptides bind to multiple subtypes, but significant subsets of peptides bound to a given HLA-B27 subtype do not bind to other subtypes or do so with greatly altered efficiency. These results indicate the importance of polymorphism outside pocket B in modulating peptide binding to HLA-B27.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8436905      PMCID: PMC2190930          DOI: 10.1084/jem.177.3.613

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

1.  The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC.

Authors:  D R Madden; J C Gorga; J L Strominger; D C Wiley
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

2.  Specificity pockets for the side chains of peptide antigens in HLA-Aw68.

Authors:  T P Garrett; M A Saper; P J Bjorkman; J L Strominger; D C Wiley
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

3.  Clonal heterogeneity of HLA-B27 cellular allorecognition. Delineation of immunodominant sites.

Authors:  P Aparicio; D Jaraquemada; S Rojo; J A López de Castro
Journal:  Eur J Immunol       Date:  1988-02       Impact factor: 5.532

4.  The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

Review 5.  HLA-B27 and HLA-A2 subtypes: structure, evolution and function.

Authors:  J A López de Castro
Journal:  Immunol Today       Date:  1989-07

6.  Molecular analysis of an HLA-A2 functional variant CLA defined by cytolytic T lymphocytes.

Authors:  A Ezquerra; N Doménech; J van der Poel; J L Strominger; M A Vega; J A López de Castro
Journal:  J Immunol       Date:  1986-09-01       Impact factor: 5.422

7.  Structure of the human class I histocompatibility antigen, HLA-A2.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

8.  Monoclonal antibody to a human histocompatibility alloantigen, HLA-A2.

Authors:  P Parham; W F Bodmer
Journal:  Nature       Date:  1978-11-23       Impact factor: 49.962

9.  Structural analysis of an HLA-B27 population variant, B27f. Multiple patterns of amino acid changes within a single polypeptide segment generate polymorphism in HLA-B27.

Authors:  S Rojo; P Aparicio; S Y Choo; J A Hansen; J A López de Castro
Journal:  J Immunol       Date:  1987-08-01       Impact factor: 5.422

10.  Structure and diversity of HLA-B27-specific T cell epitopes. Analysis with site-directed mutants mimicking HLA-B27 subtype polymorphism.

Authors:  V Calvo; S Rojo; D López; B Galocha; J A López de Castro
Journal:  J Immunol       Date:  1990-05-15       Impact factor: 5.422

View more
  9 in total

1.  PRBAM: a new tool to analyze the MHC class I and HLA-DR anchor motifs.

Authors:  Anna Mestre-Ferrer; Erika Scholz; Jepi Humet-Alsius; Iñaki Alvarez
Journal:  Immunology       Date:  2018-11-22       Impact factor: 7.397

2.  The peptide binding specificity of HLA-B27 subtypes.

Authors:  N Tanigaki; D Fruci; E Vigneti; G Starace; P Rovero; M Londei; R H Butler; R Tosi
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

3.  Long-range effects in protein--ligand interactions mediate peptide specificity in the human major histocompatibilty antigen HLA-B27 (B*2701).

Authors:  S Krebs; D Rognan; J A López de Castro
Journal:  Protein Sci       Date:  1999-07       Impact factor: 6.725

4.  Fine specificity of antigen binding to two class I major histocompatibility proteins (B*2705 and B*2703) differing in a single amino acid residue.

Authors:  D Rognan; S Krebs; O Kuonen; J R Lamas; J A López de Castro; G Folkers
Journal:  J Comput Aided Mol Des       Date:  1997-09       Impact factor: 3.686

5.  Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies.

Authors:  F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

Review 6.  HLA-B27 and HLA-B73 polymorphism and its role on antigenicity, peptide presentation, and disease susceptibility.

Authors:  J A Lopez De Castro
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

7.  Seronegative spondyloarthropathies and HLA-B27 subtyes: a study in Asian Indians.

Authors:  U Kanga; N K Mehra; C L Larrea; N M Lardy; A Kumar; T E Feltkamp
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

8.  HLA-B73: an atypical HLA-B molecule carrying a Bw6-epitope motif variant and a B pocket identical to HLA-B27.

Authors:  C Vilches; R de Pablo; M J Herrero; M E Moreno; M Kreisler
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

9.  A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition.

Authors:  Whitney A Macdonald; Anthony W Purcell; Nicole A Mifsud; Lauren K Ely; David S Williams; Linus Chang; Jeffrey J Gorman; Craig S Clements; Lars Kjer-Nielsen; David M Koelle; Scott R Burrows; Brian D Tait; Rhonda Holdsworth; Andrew G Brooks; George O Lovrecz; Louis Lu; Jamie Rossjohn; James McCluskey
Journal:  J Exp Med       Date:  2003-08-25       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.